Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Behav Brain Res ; 243: 38-43, 2013 Apr 15.
Article in English | MEDLINE | ID: mdl-23295393

ABSTRACT

In the current study, the partial NMDA receptor agonist D-cycloserine (DCS) rescued memory consolidation following systemic bacterial endotoxin exposure. DCS failed, however, to restore hippocampal BDNF mRNA levels that were diminished following a systemic administration of LPS, and did not alter NR1 or NR2C NMDA receptor subunit expression. These results extend prior research into the role of DCS in neural-immune interactions, and indicate that the detrimental effects of peripheral LPS administration on consolidation of contextual fear memory may be ameliorated with DCS treatment, though the mechanisms underlying these effects are currently unclear.


Subject(s)
Cycloserine/therapeutic use , Escherichia coli , Hippocampus/drug effects , Lipopolysaccharides/pharmacology , Memory/drug effects , Animals , Antimetabolites/pharmacology , Antimetabolites/therapeutic use , Behavior, Animal/drug effects , Cycloserine/pharmacology , Escherichia coli/drug effects , Fear/drug effects , Hippocampus/metabolism , Hippocampus/microbiology , Lipopolysaccharides/administration & dosage , Male , Mice , Mice, Inbred C57BL , Neuropsychological Tests , RNA, Messenger/drug effects , Receptors, N-Methyl-D-Aspartate/biosynthesis
2.
Behav Brain Res ; 229(1): 176-84, 2012 Apr 01.
Article in English | MEDLINE | ID: mdl-22249135

ABSTRACT

Alzheimer's disease (AD) is characterized by neuronal cell death and atrophy in regions of the adult brain, including the hippocampus and cortex, due to formation of amyloid beta (Aß) plaques and neurofibrillary tangles. The presence of these pathologies can limit normal signaling properties and ultimately lead to learning and memory deficits. Chronic inflammation has been implicated in the onset and progression of these AD-related pathologies. Our study was designed to assess the effects of peripheral inflammation on pathologies associated with AD by using the bacterial endotoxin lipopolysaccharide (LPS). C57BL/6J mice were given intraperitoneal injections of LPS or saline for 1, 3, or 7 consecutive days. Hippocampal tissue from animals receiving LPS contained significantly higher levels of Aß1-42, a peptide component of AD plaques, than did those from saline control animals. Central and peripheral pro-inflammatory cytokine levels were increased following a single injection of LPS, but retuned to baseline levels before cognitive testing began. We show that one injection of LPS leads to sickness behavior, but 7 consecutive days does not, indicating tolerance to the endotoxin. Cognitive testing was then conducted to determine if whether deficits from increased Aß1-42 was evident. Results from both Morris water maze and contextual fear conditioning revealed cognitive deficits in LPS-treated mice. In summary, multiple injections of LPS resulted in increased Aß1-42 in the hippocampus and cognitive deficits in mice.


Subject(s)
Amyloid beta-Peptides/metabolism , Cognition Disorders/chemically induced , Endotoxins/adverse effects , Hippocampus/drug effects , Hippocampus/metabolism , Lipopolysaccharides/adverse effects , Peptide Fragments/metabolism , Analysis of Variance , Animals , Cognition Disorders/blood , Conditioning, Psychological/drug effects , Drug Administration Schedule , Enzyme-Linked Immunosorbent Assay , Exploratory Behavior/drug effects , Fear/drug effects , Inflammation/chemically induced , Inflammation/complications , Inflammation/metabolism , Inflammation/pathology , Interleukin-1beta/blood , Male , Maze Learning/drug effects , Mice , Mice, Inbred C57BL , Time Factors , Weight Loss/drug effects
3.
Physiol Behav ; 105(5): 1219-25, 2012 Mar 20.
Article in English | MEDLINE | ID: mdl-21549726

ABSTRACT

Poly I:C, a viral mimetic, is a synthetic double-stranded RNA that is known to cause activation of the innate immune system, resulting in the emergence of sickness behaviors in otherwise healthy adult mice. However, the way in which such effects of poly I:C manifest themselves in aged mice are not currently known. We hypothesized that poly I:C administration would lead to burrowing deficits, but that these deficits would be exaggerated in aged subjects (19-months old) compared to young subjects (4-months old) that received the same dose. In order to associate these behavioral decrements with inflammatory factors, we measured mRNA expression of IL-1ß and IL-6 in the hippocampus and parietal cortex and peripheral protein expression of IL-6, TNF-α, MCP-1, MIP-1α, and IL-1ß in the serum. After exposure to poly I:C, aged subjects demonstrated significant impairments in their burrowing behavior, compared to younger subjects administered the same dose. These behavioral decrements coincided with increased expression of IL-6 among animals exposed to poly I:C and increased expression of IL-1ß among aged animals in the hippocampus and cortex. Furthermore, we observed an increase in peripheral poly I:C-induced IL-6, TNF-α, MCP-1, and MIP-1α, but not IL-1ß. These results indicate that virus-mediated immune activation in the aging body can lead to increased sickness behavior. Furthermore, these data indicated a possible dissociation between the effects of poly I:C on sickness behaviors in aged mice, with central expression of IL-1ß potentially playing a role in age-related impairments.


Subject(s)
Aging/immunology , Cytokines/metabolism , Illness Behavior/physiology , Poly I-C/immunology , Aging/physiology , Animals , Behavior, Animal/physiology , Biomimetic Materials , Chemokines/metabolism , Hippocampus/immunology , Hippocampus/metabolism , Interleukins/metabolism , Male , Mice , Mice, Inbred C57BL , Parietal Lobe/immunology , Parietal Lobe/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL